Ploidy and karyotype complexity are powerful prognostic indicators in the Ewing's sarcoma family of tumors: A study by the United Kingdom Cancer Cytogenetics and the Children's Cancer and Leukaemia Group-Reference-Cited by-同舟云学术

Ploidy and karyotype complexity are powerful prognostic indicators in the Ewing's sarcoma family of tumors: A study by the United Kingdom Cancer Cytogenetics and the Children's Cancer and Leukaemia Group

Published:2008 Issue:3 Volume:47 Page:207-220
ISSN:1045-2257
Container-title:Genes, Chromosomes and Cancer
language:en
Short-container-title:Genes Chromosom. Cancer

Author:

Roberts Paul,Burchill Susan A.,Brownhill Samantha,Cullinane Catherine J.,Johnston Colin,Griffiths Mike J.,McMullan Dom J.,Bown Nick P.,Morris Stephen P.,Lewis Ian J.

Publisher

Wiley

Subject

Cancer Research,Genetics

Reference44 articles.

1. EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing's sarcoma.

2. Prognostic impact of P53 status in Ewing sarcoma

3. Recurrent gains of 1q, 8 and 12 in the Ewing family of tumours by comparative genomic hybridization

4. EWS/FLI-1 fusion signal inserted into chromosome 11 in one patient with morphologic features of Ewing sarcoma, but lacking t(11;22)

5. Cytogenetic characterization of Ewing tumors with high-ploidy

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterization of transcriptional heterogeneity and novel therapeutic targets using single cell RNA-sequencing of primary and circulating Ewing sarcoma cells;2024-01-20

2. DNA Methylation Profiling Distinguishes Adamantinoma-Like Ewing Sarcoma From Conventional Ewing Sarcoma;Modern Pathology;2023-11

3. Complex/cryptic EWSR1::FLI1/ERG Gene Fusions and 1q Jumping Translocation in Pediatric Ewing Sarcomas;Genes;2023-05-24

4. Ewing sarcoma genomics and recent therapeutic advancements;Pediatric Hematology Oncology Journal;2023-03

5. An international working group consensus report for the prioritization of molecular biomarkers for Ewing sarcoma;npj Precision Oncology;2022-09-17